-
'Call of Duty' slammed for using real Seoul crowd crush footage
-
Hello Kitty firm apologises, scraps Japan TV tie-up after China anger
-
TotalEnergies profit hits record on high oil prices
-
Taiwan says Pakistan briefly closed airspace to Taiwanese flights
-
Key of seethe: I.Coast row with Sahel juntas spills into concert halls
-
'My blood was spilled here': a year on, Tanzania unable to mourn election violence
-
Romanian writer Cartarescu hails books as balm in turmoil
-
Afghanistan opium poppy cultivation surges despite Taliban govt ban: UN
-
Mbappe, Real Madrid and La Liga face long road to redemption in China
-
No World Series miracle for weary Rays
-
North Korea fires 'around a dozen' ballistic missiles into East Sea
-
Miami Heat earn first win of NBA season with Antetokounmpo
-
Brewers catcher Contreras named World Series MVP
-
Brewers beat Rays 4-1 to capture first World Series title
-
Asian stock markets fluctuate after mixed tech results
-
Philippine island fights rising seas with nature, not concrete
-
Samsung logs record quarterly profits despite investor AI jitters
-
Bangladesh presses India before Ganges water treaty expires
-
Miami stumble to draw against Cincinnati despite Suarez strike
-
Trump accuses Alaska Democrats of fraud over same-name scandal
-
Bangladesh scrambling as Ganges water treaty to expire
-
Spain mourns after latest train tragedy kills 68
-
England in peril with Rugby League World Cup semi spots at stake
-
Trump's border: quiet, but few people are happy
-
Antonelli ready to rewrite the Formula One record books in Mexico
-
Australian defence chief says China military buildup creating 'pressure' in SE Asia
-
EU, Canada to build 'new chapter' in alliance at Montreal summit
-
Guardian Metal Resources PLC Announces Investor Presentation
-
Storm Preparedness: The Equipment Worth Investing In
-
Wealthy.ai Premium Domain Offered for Strategic Acquisition as AI Reshapes Wealth Management
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 29
-
Trifecta Gold Announces Drill Results from Rye Project, Yukon
-
Tocvan Pilot Mine Trench at Gran Pilar Averages 4.6 g/t Au With Samples Up to 24.4 g/t Au; New Zone 1.3 km East Returns Up to 234 g/t Ag
-
No penalty practice? No problem for Man City in shoot-out win
-
Argentine football fan jailed for threats over Di Maria return
-
Microsoft beats expectations fueled by Azure cloud business
-
Liverpool beat Chelsea in League Cup shoot-out, Man City survive scare
-
Chelsea win as Bayern draw with Madrid in Women's Champions League
-
Inter leave it late again in Serie A as AC Milan, Juventus lose
-
Kane watches as Bayern cruise into German Cup last 16
-
Shares in Google owner Alphabet plummet on profit miss, ad slowdown
-
Bayern boss Kompany out of hospital after meningeal irritation
-
Putin hails Elon Musk as 'truly a genius'
-
Shares in Google owner Alphabet sink on profit miss, ad slowdown
-
US stocks eye big tech earnings as Fed holds rates steady
-
Chelsea win as Bayern and Madrid draw in Women's Champions League
-
US Fed holds interest rates steady despite 'too high' inflation
-
Made with munitions from the Falklands War, a 'Chalice of Peace' for the pope
-
Rwanda cannot be blamed for what happens in DR Congo, FM says
-
Pioneering US labor leader Dolores Huerta dies at 96
TailorMed and Flatiron Health Partner to Expand Medication Access and Support Across Oncology Care
Collaboration brings end-to-end medication support to Flatiron's network, helping community oncology practices connect patients to the resources they need to start and stay on therapy
NEW YORK, NY / ACCESS Newswire / May 4, 2026 / TailorMed, the leading medication success platform, today announced a new partnership with Flatiron Health to offer access to comprehensive medication support across Flatiron's network of oncology providers. Through this collaboration, TailorMed becomes part of the Flatiron Vendor Network, enabling practices to more easily connect patients to financial assistance, support programs, and adherence resources throughout the medication journey.
TailorMed's end-to-end platform integrates into existing workflows to proactively identify patients at risk, match them to available resources, and streamline enrollment, helping care teams reduce delays and improve patient outcomes without adding complexity.
"Access and affordability remain some of the biggest barriers in oncology care," said Srulik Dvorsky, CEO of TailorMed. "By partnering with Flatiron, we're able to extend that support directly into the workflows that providers already rely on, helping more patients to get the therapy they need and stay on it."
"Flatiron is building connected, clinically informed technology that helps providers deliver better care, faster," said Quincy Weatherspoon, Vice President & GM, Flatiron Point of Care Solutions at Flatiron Health. "Our partnership with TailorMed expands the resources available across our OncoEMR network, helping providers navigate financial barriers and ensure more patients can access and stay on the therapies they need."
TailorMed supports the full lifecycle of medication access, combining enterprise workflow tools with patient-facing solutions such as a virtual copay wallet and resource hub. As part of Flatiron's vendor network, this approach brings greater visibility and coordination to a historically fragmented process, helping ensure support reaches patients wherever care happens.
About TailorMed
TailorMed is the medication success platform removing every barrier across the patient medication journey, from access and affordability through adherence and ongoing care. Through a connected network spanning 945+ hospitals, 4,700+ clinics, 3,100+ pharmacies, 100+ life sciences programs, and 6,000+ support programs, TailorMed has supported over 75 million patients and secured more than $7.4 billion in financial assistance since 2020. TailorMed's platform, including TailorMed Core, TailorMed Connect, TailorMed Complete, TailorMed Amplify, and TailorMed Alliance, connects patients, providers, pharmacies, and life sciences companies through one coordinated network designed to reach every patient at every step of their medication journey. Learn more at tailormed.com
About Flatiron
Flatiron Health is a healthtech company expanding the possibilities for point-of-care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients' real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.
PR Contact:
Jen Martin
[email protected]
Glenn Goldberg
Parallel Communications Group
+1 516 776-3282
[email protected]
Flatiron Health Media Contact:
Nina Toor
[email protected]
SOURCE: TailorMed
View the original press release on ACCESS Newswire
B.Finley--AMWN